MediWound Ltd. (Nasdaq: MDWD), which has developed and markets a burn treatment compound that is undergoing clinical trials for the treatment of wounds, announced it has raised $30 million. The collection was at market price. Investors include New Era Capital Partners, Deep Insight, IBF and Discount Capital.
MediWound Announces $30M Raise for Clinical Trials and Production Expansion
![](http://ibf.fund/wp-content/uploads/2022/10/Unknown-e1666179152312.jpeg)